About Careers Internship MedBlog Contact us
Medindia LOGIN REGISTER
Advertisement

Aurobindo Pharma Ltd. Gets Approval for Famciclovir

by Dr. Trupti Shirole on March 23, 2011 at 4:30 PM
Font : A-A+

 Aurobindo Pharma Ltd. Gets Approval for Famciclovir

The US Food & Drug Administration (US FDA) has given final approval for Aurobindo Pharma Ltd. for the abbreviated new drug application (ANDA) for famciclovir tablets 125mg, 250mg and 500mg.

Famciclovir tablet is the generic version of Novartis Pharmaceuticals and is indicated for the treatment of recurrent mucocutaneous herpes simplex infections in HIV-infected patients and also for suppression of recurrent genital herpes in immunocompetent patients.

Advertisement

The Aurobindo Pharma Ltd. now has a total of 132 ANDA approvals from US FDA.


Source: Medindia
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
What's New on Medindia
Alarming Cesarean Section Trends in India - Convenience or Compulsion of Corporate Healthcare
Quiz on Low-Calorie Diet for Diabetes
World Heart Day in 2022- Use Heart for Every Heart
View all
Recommended Reading
News Archive
Date
Category
Advertisement
News Category

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Drug Toxicity 

Most Popular on Medindia

Calculate Ideal Weight for Infants Blood - Sugar Chart Sinopril (2mg) (Lacidipine) Iron Intake Calculator Accident and Trauma Care Noscaphene (Noscapine) Daily Calorie Requirements Blood Donation - Recipients Selfie Addiction Calculator Loram (2 mg) (Lorazepam)
This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use
×

Aurobindo Pharma Ltd. Gets Approval for Famciclovir Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests